Search research articles
Contact Us
Filters
Showing results (21-30 of 176) with videos related to
Page
of 18
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 19, 2015
Classic hallucinogens in the treatment of addictions
Michael P Bogenschutz, Matthew W Johnson
International Review of Neurobiology
|
June 20, 2025
Psychedelics and substance use disorder treatment
Caitlin M DuPont, Matthew W Johnson
Experimental and Clinical Psychopharmacology
|
July 22, 2021
Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs
David J Cox, Matthew W Johnson
Drug and Alcohol Dependence
|
January 25, 2020
The drug purity discounting task: Ecstasy use likelihood is reduced by probabilistic impurity according to harmfulness of adulterants
Sean B Dolan, Matthew W Johnson
Frontiers in Psychiatry
|
June 18, 2020
Editorial: Hallucinogens and Entactogens: Establishing a New Class of <i>Psychotherapeutic</i> Drugs?
Felix Müller, Matthew W Johnson, Stefan Borgwardt
Experimental and Clinical Psychopharmacology
|
May 2, 2007
Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers
Matthew W Johnson, Warren K Bickel, Forest Baker
Addictive Behaviors
|
October 30, 2016
Knowledge about nicotine among HIV-positive smokers: Implications for tobacco regulatory science policy
Lauren R Pacek, Olga Rass, Matthew W Johnson
Expert Opinion on Investigational Drugs
|
October 23, 2023
Assessing potential of psilocybin for depressive disorders
Zofia Kozak, Matthew W Johnson, Scott T Aaronson
Journal of Abnormal Psychology
|
August 29, 2003
Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude
Forest Baker, Matthew W Johnson, Warren K Bickel
Learning & Behavior
|
January 7, 2006
Relationship between cooperation in an iterated prisoner's dilemma game and the discounting of hypothetical outcomes
Richard Yi, Matthew W Johnson, Warren K Bickel
Page
of 18
Search research articles
Search
Showing results (21-30 of 176) with videos related to
Sort By:
Page
of 18
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 19, 2015
Classic hallucinogens in the treatment of addictions
Michael P Bogenschutz, Matthew W Johnson
International Review of Neurobiology
|
June 20, 2025
Psychedelics and substance use disorder treatment
Caitlin M DuPont, Matthew W Johnson
Experimental and Clinical Psychopharmacology
|
July 22, 2021
Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs
David J Cox, Matthew W Johnson
Drug and Alcohol Dependence
|
January 25, 2020
The drug purity discounting task: Ecstasy use likelihood is reduced by probabilistic impurity according to harmfulness of adulterants
Sean B Dolan, Matthew W Johnson
Frontiers in Psychiatry
|
June 18, 2020
Editorial: Hallucinogens and Entactogens: Establishing a New Class of <i>Psychotherapeutic</i> Drugs?
Felix Müller, Matthew W Johnson, Stefan Borgwardt
Experimental and Clinical Psychopharmacology
|
May 2, 2007
Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers
Matthew W Johnson, Warren K Bickel, Forest Baker
Addictive Behaviors
|
October 30, 2016
Knowledge about nicotine among HIV-positive smokers: Implications for tobacco regulatory science policy
Lauren R Pacek, Olga Rass, Matthew W Johnson
Expert Opinion on Investigational Drugs
|
October 23, 2023
Assessing potential of psilocybin for depressive disorders
Zofia Kozak, Matthew W Johnson, Scott T Aaronson
Journal of Abnormal Psychology
|
August 29, 2003
Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude
Forest Baker, Matthew W Johnson, Warren K Bickel
Learning & Behavior
|
January 7, 2006
Relationship between cooperation in an iterated prisoner's dilemma game and the discounting of hypothetical outcomes
Richard Yi, Matthew W Johnson, Warren K Bickel
Page
of 18